目标6块,止损5.1以下查看全文
chuminhua2020-10-20 22:10
10/19, Aptinyx$Aptinyx(APTX)$ 股价在盘后交易中涨幅高达92%,此前该公司报告称,其实验性药物NYX-783在创伤后应激障碍(PTSD)患者的II期试验中取得了积极的结果。基于这些数据,Aptinyx表示,预计将在2021年启动该口服NMDA受体调节剂的首个关键性研究。查看全文
7X24快讯2020-10-20 04:55
生物制药公司Aptinyx(APTX)美股盘后飙涨49%;该公司用于治疗创伤后应激障碍(PTSD)的药物NYX-783的二期试验显示出积极、有统计学意义的顶线数据。查看全文
$Aptinyx(APTX)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-23-067587 Act: 34 Size: 1 MB 网页链接
$Aptinyx(APTX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-064156 Act: 33 Size: 27 KB 网页链接
$Aptinyx(APTX)$ RW Registration Withdrawal Request Accession Number: 0001104659-23-064141 Act: NE Size: 5 KB 网页链接
$Aptinyx(APTX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-064149 Act: 33 Size: 27 KB 网页链接
$Aptinyx(APTX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-064153 Act: 33 Size: 27 KB 网页链接
$Aptinyx(APTX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-064157 Act: 33 Size: 27 KB 网页链接
$Aptinyx(APTX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-23-063435 Act: 34 Size: 1 MB 网页链接
$Aptinyx(APTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-23-010197 Act: 34 Size: 4 MB 网页链接
$Aptinyx(APTX)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001104659-23-060844 Act: 34 Size: 27 KB 网页链接
$Aptinyx(APTX)$ 8-K Current report, item 3.01 Accession Number: 0001104659-23-058779 Act: 34 Size: 200 KB 网页链接